QNTM
Quantum BioPharma·NASDAQ
--
--(--)
--
--(--)
7.52 / 10
Outperform
Capital flow assessment yields 7.52/10, denoting robust fund flow characteristics. Small trends show positive liquidity, while overall, block, Medium, Large, and Extra-large patterns exhibit negative trends, indicating a nuanced liquidity outlook.
Fund Flow Rating
What is the analyst consensus for QNTM?
- QNTM holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.52/10 (Outperform).
